Prevalence and Predictors of Warfarin Use in Patients With Atrial Fibrillation at Low or Intermediate Risk and Relation to Thromboembolic Events

CLINICAL AND TRANSESOPHAGEAL ECHOCARDIOG

CLINICAL AND TRANSESOPHAGEAL ECHOCARDIOGRAPHIC VARIABLES FOR THROMBOEMBOLIC RISK PREDICTION IN PATIENTS WITH ATRIAL FIBRILLATION AT LOW-INTERMEDIATE RISK

✍ Keiko Nakagawa; Tadakazu Hirai; Kazumasa Ohara; Nobuyuki Fukuda; Satoshi Numa; S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Drug interactions and risk of acute blee

Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

✍ Gasse, Christiane; Hollowell, Jennifer; Meier, Christoph R.; Haefeli, Walter E. 📂 Article 📅 2005 🏛 Schattauer 🌐 English ⚖ 211 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

## Objectives: The objective of this study was to compare the predictive performance of bleeding risk-estimation tools in a cohort of patients with atrial fibrillation (af) undergoing anticoagulation. ## Background: Three bleeding risk-prediction schemes have been derived for and validated in pat

OP-042: EVALUATING THE PREVALENCE OF RIS

OP-042: EVALUATING THE PREVALENCE OF RISK FACTORS FOR THROMBOEMBOLISM IN OUR ATRIAL FIBRILLATION PATIENTS AND ADEQUACY OF ANTITHROMBOTIC THERAPY USED ACCORDING TO CHA2DS2VACS RISK STRATIFICATION

✍ E. Karacaglar; B. Yetis; H. Corut; B. Ersoy; K. Yilmaz; B. Ozin; H. Muderrisoglu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB